CollPlant Biotechnologies (CLGN) Change in Receivables (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Change in Receivables of -$7000.0 for Q1 2026, down 104.67% on a YoY basis from $150000.0 in Q1 2025, and down 170.0% quarter-over-quarter from $10000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Change in Receivables (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Change in Receivables for 9 years, with the latest figure at -$7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 104.67% year-over-year to -$7000.0; the trailing twelve-month figure through Mar 2026 stood at -$8000.0 (down 108.89% YoY), and the FY2025 full-year result was $149000.0, up 199.33% from the prior year.
- Change in Receivables for Q1 2026 stood at -$7000.0, down from $10000.0 in the prior quarter.
- The five-year high for Change in Receivables was $10.2 million in Q3 2023, with the low at -$9.8 million in Q2 2023.
- Historically, Change in Receivables has averaged $34866.7 across 5 years, with a median of -$7000.0 in 2026.
- Annual changes were most pronounced in 2023 — Change in Receivables slumped 109200.0% — and 2025, when it surged 266.67%.
- CollPlant Biotechnologies' Change in Receivables stood at $261000.0 in 2022, then sank by 98.47% to $4000.0 in 2023, then sank by 3725.0% to -$145000.0 in 2024, then soared by 106.9% to $10000.0 in 2025, then slumped by 170.0% to -$7000.0 in 2026.
- The last three Change in Receivables figures came in at -$7000.0 (Q1 2026), $10000.0 (Q4 2025), and -$11000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Jun 30, 2024 | -160,000.00 |
| Jun 30, 2024 | -160,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 10.16 Mn |
| Sep 30, 2023 | 10.16 Mn |